Phibro Animal Health (NASDAQ:PAHC) Upgraded at StockNews.com

StockNews.com upgraded shares of Phibro Animal Health (NASDAQ:PAHC) from a hold rating to a buy rating in a report published on Saturday.

PAHC has been the subject of a number of other research reports. Morgan Stanley upped their target price on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a report on Tuesday, December 17th. Barclays lifted their price target on shares of Phibro Animal Health from $20.00 to $22.00 and gave the company an “underweight” rating in a research report on Monday, February 10th. Two analysts have rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat, Phibro Animal Health presently has a consensus rating of “Hold” and a consensus price target of $21.00.

Phibro Animal Health Stock Performance

Shares of NASDAQ PAHC opened at $21.85 on Friday. The company has a market capitalization of $884.99 million, a PE ratio of 45.52, a price-to-earnings-growth ratio of 0.45 and a beta of 0.58. The company has a debt-to-equity ratio of 2.99, a quick ratio of 1.37 and a current ratio of 3.20. The company’s fifty day moving average price is $22.60 and its 200 day moving average price is $22.59. Phibro Animal Health has a 1 year low of $12.07 and a 1 year high of $26.55.

Phibro Animal Health (NASDAQ:PAHC) last announced its earnings results on Wednesday, February 5th. The company reported $0.54 earnings per share for the quarter, topping the consensus estimate of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. On average, research analysts predict that Phibro Animal Health will post 1.95 earnings per share for the current year.

Phibro Animal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Wednesday, March 5th will be given a dividend of $0.12 per share. The ex-dividend date of this dividend is Wednesday, March 5th. This represents a $0.48 annualized dividend and a dividend yield of 2.20%. Phibro Animal Health’s dividend payout ratio is presently 100.00%.

Institutional Trading of Phibro Animal Health

A number of large investors have recently made changes to their positions in the company. Thrivent Financial for Lutherans lifted its holdings in Phibro Animal Health by 23.1% during the 3rd quarter. Thrivent Financial for Lutherans now owns 20,791 shares of the company’s stock worth $468,000 after buying an additional 3,907 shares during the last quarter. Segall Bryant & Hamill LLC lifted its stake in Phibro Animal Health by 1.7% during the third quarter. Segall Bryant & Hamill LLC now owns 174,569 shares of the company’s stock worth $3,931,000 after purchasing an additional 2,971 shares during the last quarter. Algert Global LLC boosted its holdings in Phibro Animal Health by 521.1% in the third quarter. Algert Global LLC now owns 71,335 shares of the company’s stock valued at $1,606,000 after purchasing an additional 59,850 shares in the last quarter. FMR LLC increased its stake in Phibro Animal Health by 22.7% in the third quarter. FMR LLC now owns 39,310 shares of the company’s stock valued at $885,000 after purchasing an additional 7,270 shares during the last quarter. Finally, Quantbot Technologies LP acquired a new stake in Phibro Animal Health during the third quarter worth approximately $70,000. 99.34% of the stock is currently owned by hedge funds and other institutional investors.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.